Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Advertisement A 2022 study on women with PMOS compared berberine (500 milligrams twice a day) to other agents (including metformin)
Part 5: The IRAs Hidden Patent Reform How the Inflation Reduction Act Rewrites the Exclusivity Map Key Takeaways: Part 5 The Inflation Reduction Act (IRA) of 2022 created a new, non-patent-based Loss of Exclusivity event: mandatory price negotiation (effectively price setting) for high-spending single-source drugs in Medicare, backed by a prohibitive excise tax for non-compliance
Patient-Centered Medicine
Mongioi et al
US$ 27.59
US$ 28.52
US$ 25.18
US$ 28.01
US$ 29.83
US$ 20.21
US$ 24.43
US$ 22.23
US$ 22.09
